首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1392090

聯合化療市場：依藥物類型、製劑環境、給藥途徑、病患類型、癌症類型、配銷通路、製劑方法、包裝類型、法規遵循、地區

Compounding Chemotherapy Market, By Drug Type, By Compounding Setting, By Route of Administration, By Patient Type, By Cancer Type, By Distribution Channel, By Compounding Method, By Packaging Type, By Regulatory Compliance, By Geography

出版日期: 2023年11月16日 | 出版商:

Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年全球聯合化療市場規模為52.9億美元，預估2023年至2030年年複合成長率為4.9%，2030年達74.1億美元。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	52.9億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	4.90%	2030年市場規模預測	74.1億美元

圖 1. 2023 年按地區分類的聯合化療全球市場佔有率(%)

合併化療是指將藥物成分客製化為適合個別患者需求的藥物。這主要是由於全球癌症發生率不斷上升以及對專門藥物製劑的需求。隨著癌症治療變得更加個體化，化合物在為患者提供適合其特定疾病、狀況和易感性的正確配方方面發揮著重要作用。日益成長的老年人口（更容易患癌症）、對精準醫療和標靶治療的日益關注以及成藥的稀缺是推動全球普及聯合化療服務的一些關鍵因素。

市場動態：

癌症、骨髓疾病和免疫系統問題等疾病的盛行率不斷上升也可能推動預測期內全球聯合化療市場的成長。處方藥成本的上漲和支付政策的變化預計將在預測期內再次促進全球聯合化療市場的成長。增加產品對消費者健康的益處為全球聯合化療市場創造了新的機會。醫院和醫療產業對聯合化療和藥物的認知不斷提高也推動了市場擴張。

根據世界衛生組織 (WHO) 統計，自 2000 年以來，受癌症影響的人數幾乎增加了一倍，預計未來 20 年將增加 70% 以上。對個體化治療選擇和基於價值的護理模式的認知不斷提高，促使腫瘤科醫生實施藥房服務。此外，成藥的缺乏，特別是針對兒童癌症的非處方藥的缺乏，為該市場的參與企業提供了成長機會。然而，污染風險、製備複雜配方的技術挑戰以及各國法規環境不一致也可能阻礙市場擴張。 3D 列印在藥房配藥中的日益成長的應用可能會在未來幾年為改進藥物傳輸和個體化給藥設計開闢新途徑。

本研究的主要特點

本報告詳細分析了全球聯合化療市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球聯合化療市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
全球聯合化療市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球聯合化療市場的各種策略矩陣，將有助於相關人員做出決策。

Braun Melsungen AG
Fagron NV
PharMEDium Services, LLC（AmerisourceBergen Corporation）
Baxter International Inc.
Fresenius Kabi AG
Advanced Pharma, Inc.
McGuff Compounding Pharmacy Services, Inc.
Central Admixture Pharmacy Services, Inc.（CAPS）
Institutional Pharmacy Solutions, LLC
Wedgewood Pharmacy
Medisca Inc.
Dougherty's Holdings, Inc.
PharMEDium Services, LLC（AmerisourceBergen Corporation）
BioScrip, Inc.

第16章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5892

The Global Compounding Chemotherapy Market size was valued at US$ 5.29 Bn in 2023 and is projected to reach US$ 7.41 Bn by 2030, growing at a CAGR of 4.9% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.29 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.90%	2030 Value Projection:	US$ 7.41 Bn

Figure 1. Global Compounding Chemotherapy Market Share (%), by Region, 2023

Compounding chemotherapies refer to the customization of pharmaceutical ingredients into medication tailored to individual patient needs. This has been largely driven by the rise in cancer prevalence worldwide and the need for specialized drug formulations. As cancer treatments become more personalized, compounding plays a crucial role in providing patients with formulations suited to their specific disease, condition, or sensitivity. Growing geriatric population prone to developing cancers, increasing emphasis on precision medicine and targeted therapies, and shortages of commercially available drugs are some of the key factors fueling the adoption of compounding chemotherapy services globally.

Market Dynamics:

The increasing prevalence of illnesses like cancer, bone marrow conditions, and immune system problems will continue to fuel the growth of the global compounding chemotherapy market over the forecast period. Increasing costs for prescription drugs and changing payment policies are again expected to augment global compounding chemotherapy market growth over the forecast period. Rising consumer health benefits from the products will create new opportunities for the global compounding chemotherapy market. Hospitals and the healthcare industry are becoming more aware of compounded chemotherapy treatments or medicines, which is also assisting in the market's expansion.

According to the World Health Organization, the cancer burden has nearly doubled since 2000 and is expected to grow by over 70% in the next two decades. Increased awareness about personalized treatment options and value-based healthcare models is encouraging oncology practitioners to adopt compounding services. The shortage of commercially manufactured drugs, especially for pediatric cancer, also presents growth opportunities for players in this market. However, risks of contamination, technical challenges in preparing complex formulations, and an inconsistent regulatory environment across countries could hinder the market expansion to some extent. The growing application of 3D printing in pharmacy compounding is likely to open up new avenues, allowing for improved drug delivery and personalized dosage designs in the coming years.

Key features of the study:

This report provides in-depth analysis of the global compounding chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global compounding chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include B. Braun Melsungen AG, Fagron NV, PharMEDium Services, LLC (AmerisourceBergen Corporation), Baxter International Inc., Fresenius Kabi AG, Advanced Pharma, Inc., McGuff Compounding Pharmacy Services, Inc., Central Admixture Pharmacy Services, Inc. (CAPS), Institutional Pharmacy Solutions, LLC, Wedgewood Pharmacy, Medisca Inc., Dougherty's Holdings, Inc., PharMEDium Services, LLC (AmerisourceBergen Corporation), BioScrip, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global compounding chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding chemotherapy market

Global Compounding Chemotherapy Market Detailed Segmentation:

By Drug Type:
- Cytotoxic Drugs
- Hormonal Agents
- Immunomodulatory Agents
- Targeted Therapies
- Supportive Care Drugs
By Compounding Setting:
- Hospital Compounding
- Compounding Pharmacies
- Specialty Clinics
- Homecare Settings
By Route of Administration:
- Intravenous (IV)
- Oral
- Subcutaneous (SC)
- Intramuscular (IM)
- Intrathecal (IT)
By Patient Type:
- Adult Patients
- Pediatric Patients
- Geriatric Patients
By Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
- Lymphoma
- Other specific cancer types
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Compounding Method:
- Aseptic Compounding
- Non-aseptic Compounding
By Packaging Type:
- Vials
- Ampoules
- Pre-filled Syringes
- Bottles
By Regulatory Compliance:
- USP Chapter <797> Compliance
- FDA Regulations
- EMA Regulations
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profile:
- Braun Melsungen AG
- Fagron NV
- PharMEDium Services, LLC (AmerisourceBergen Corporation)
- Baxter International Inc.
- Fresenius Kabi AG
- Advanced Pharma, Inc.
- McGuff Compounding Pharmacy Services, Inc.
- Central Admixture Pharmacy Services, Inc. (CAPS)
- Institutional Pharmacy Solutions, LLC
- Wedgewood Pharmacy
- Medisca Inc.
- Dougherty's Holdings, Inc.
- BioScrip, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Compounding Chemotherapy, By Drug Type
- Market Compounding Chemotherapy, By Compounding Setting
- Market Compounding Chemotherapy, By Route of Administration
- Market Compounding Chemotherapy, By Patient Type
- Market Compounding Chemotherapy, By Cancer Type
- Market Compounding Chemotherapy, By Distribution Channel
- Market Compounding Chemotherapy, By Compounding Method
- Market Compounding Chemotherapy, By Packaging Type
- Market Compounding Chemotherapy, By Regulatory Compliance
- Market Compounding Chemotherapy, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing demand for Personalized Medicine
Increasing prevalence of illnesses like cancer
- Restraints
The High cost of compounding chemotherapeutic products
- Opportunities
Rising consumer health benefits from the products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Compounding Chemotherapy Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Compounding Chemotherapy Market , By Drug Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cytotoxic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Hormonal Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Immunomodulatory Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Targeted Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Supportive Care Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Compounding Chemotherapy Market , By Compounding Setting, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Compounding Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Compounding Chemotherapy Market , By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Intrathecal (IT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Compounding Chemotherapy Market , By Patient Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pediatric Patients
Geriatric Patients

9. Compounding Chemotherapy Market , By Cancer Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Lung Cancer
Colorectal Cancer
Prostate Cancer
Leukemia
Lymphoma
Other specific cancer types

10. Compounding Chemotherapy Market , By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies

11. Compounding Chemotherapy Market , By Compounding Method, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Aseptic Compounding
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Non-aseptic Compounding

12. Compounding Chemotherapy Market , By Packaging Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Ampoules
Pre-filled Syringes
Bottles

13. Compounding Chemotherapy Market , By Regulatory Compliance, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
USP Chapter <797> Compliance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
FDA Regulations
EMA Regulations

14. Compounding Chemotherapy Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Setting, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Compounding Method, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Regulatory Compliance, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
GCC
Israel
Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa

15. Competitive Landscape

Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fagron NV
PharMEDium Services, LLC (AmerisourceBergen Corporation)
Baxter International Inc.
Fresenius Kabi AG
Advanced Pharma, Inc.
McGuff Compounding Pharmacy Services, Inc.
Central Admixture Pharmacy Services, Inc. (CAPS)
Institutional Pharmacy Solutions, LLC
Wedgewood Pharmacy
Medisca Inc.
Dougherty's Holdings, Inc.
PharMEDium Services, LLC (AmerisourceBergen Corporation)
BioScrip, Inc.
Analyst Views